Tolvaptan (Jinarc®) In this section Best-value medicines Data Snapshots and Publications Glucose monitoring Preferred Drugs Prescribing Tips and Tools Prescribing and Cost Guidance Managed Access Protocols Atopic Dermatitis Bempedoic Acid Berotralstat (Orladeyo®) Bulevirtide (Hepcludex®) Eculizumab Entrectinib (Rozlytrek®) - Lung Cancer Entrectinib (Rozlytrek®) - NTRK gene fusion Fostemsavir (Rukobia®) Inotersen (Tegsedi®) Lanadelumab (Takhzyro®) Larotrectinib (Vitrakvi®) Lidocaine (Versatis®) Liraglutide (Saxenda®) Migraine Nusinersen (Spinraza®) Odevixibat (Bylvay®) Onasemnogene abeparvovec (Zolgensma®) Patisiran (Onpattro®) PCSK9 Inhibitors Risdiplam (Evrysdi®) Rivaroxaban 2.5mg Romosozumab (Evenity®) Sacubitril and Valsartan (Entresto®) Severe Asthma – Dupilumab (Dupixent®) Tafamidis (Vyndaqel®) Teduglutide (Revestive®) THC/CBD (Sativex®) Tolvaptan (Jinarc®) Voretigene neparvovec (Luxturna®) Vutrisiran (Amvuttra®) Position Papers Evaluation Reports Consultation Lidocaine 5% plaster Oral nutritional supplements Opioids BZRA for anxiety & insomnia Guidance on Shortages Events The Team / Contact Us
